Nutraceutical: A Promising Era for Cardiovascular Disease Prevention and Treatment
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, with nearly 18–20 million deaths annually. Conventional pharmacological and surgical therapies have improved survival but are often associated with side effects, high costs, and limited long-term efficacy. Nutraceuticals—bioactive compounds derived from dietary sources such as omega-3 fatty acids, phytosterols, polyphenols, vitamins, probiotics, and herbal bioactives—have emerged as promising adjuncts for the prevention and management of CVD. These agents exert cardioprotective effects through diverse mechanisms, including lipid-lowering, antioxidant, anti-inflammatory, anti-thrombotic, and endothelial-protective pathways. Clinical trials such as GISSI-Prevenzione, REDUCE-IT, PREDIMED, and Q-SYMBIO provide strong evidence supporting the efficacy of specific nutraceuticals, particularly omega-3 fatty acids, plant sterols, Coenzyme Q10, and polyphenols, in reducing cardiovascular risk and improving outcomes in patients with heart disease. Furthermore, plant-based diets rich in fruits, vegetables, legumes, and whole grains—naturally enriched with nutraceuticals—demonstrate significant protective benefits against CVD progression. However, challenges remain regarding variability in supplement quality, bioavailability, and the need for standardized dosing. Future directions include integration of nutraceuticals into precision nutrition, exploration of gut microbiota interactions, and development of novel delivery systems to enhance clinical effectiveness. Overall, nutraceuticals represent a cost-effective, multi-targeted, and accessible strategy that complements conventional therapies, offering a promising era in the prevention and treatment of cardiovascular disease.
Keywords: Nutraceuticals; Cardiovascular disease; Omega-3 fatty acids; Polyphenols; Probiotics; Functional foods; Antioxidants; Precision nutrition.
Keywords:
Nutraceuticals, Cardiovascular disease, Omega-3 fatty acids, Polyphenols, Probiotics, Functional foods, Antioxidants, Precision nutritionDOI
https://doi.org/10.22270/jddt.v15i10.7389References
1. Zuraini NZ, Sekar M, Wu YS, Gan SH, Bonam SR, Mat Rani NN, Begum MY, Lum PT, Subramaniyan V, Fuloria NK, Fuloria S. Promising nutritional fruits against cardiovascular diseases: An overview of experimental evidence and understanding their mechanisms of action. Vascular health and risk management. 2021 Nov 23:739-69. https://doi.org/10.2147/VHRM.S328096 PMid:34858028 PMCid:PMC8631183
2. Fleenor BS, Carlini NA, Martens CR. Nutraceuticals in the prevention and therapeutic of cardiovascular and cerebrovascular disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 2023 May 1;43(3):162-9. https://doi.org/10.1097/HCR.0000000000000773 PMid:36656154
3. Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis. Alzheimers Dement (Amst). 2017; 7:69-87. https://doi.org/10.1016/j.dadm.2017.01.005 PMid:28275702 PMCid:PMC5328683
4. Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(9):1237-1263. https://doi.org/10.1016/j.jacc.2019.07.012 PMid:31466622 PMCid:PMC6719727
5. Sharma M, Vidhya CS, Ojha K, Yashwanth BS, Singh B, Gupta S, Pandey SK. The role of functional foods and nutraceuticals in disease prevention and health promotion. Eur. J. Nutr. Food Saf. 2024 Feb 19;16:61-83. https://doi.org/10.9734/ejnfs/2024/v16i21388
6. DeFelice SL. The nutraceutical revolution: Its impact on food industry R&D. Trends in Food Science & Technology. 1995;59:59- 61. https://doi.org/10.1016/S0924-2244(00)88944-X
7. Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy diet for cardiovascular disease prevention: where are we now?. Vascular health and risk management. 2023 Dec 31:237-53. https://doi.org/10.2147/VHRM.S379874 PMid:37113563 PMCid:PMC10128075
8. Woodruff RC, Tong X, Loustalot FV, Khan SS, Shah NS, Jackson SL, Vaughan AS. rdiovascular Disease Mortality Trends, 2010-2022: An Update with Final Data. Am J Prev Med. 2025 Feb;68(2):391-395. https://doi.org/10.1016/j.amepre.2024.09.014 PMid:39321995
9. Hu B, Feng J, Wang Y, Fan Y, Hou L. Global, regional and national temporal trends in prevalence for cardiovascular diseases in women of childbearing age, from 1990 to 2019: An age-period-cohort analysis. Heliyon. 2024 Mar 25;10(7):e28526. https://doi.org/10.1016/j.heliyon.2024.e28526 PMid:38601535 PMCid:PMC11004743
10. Banerjee S, Chaudhry M, Brewer J, Chen Y, Khasiyev F, Soudagar Turkey M. Unprovoked Atypical Absence Status Epilepticus in a Patient With Allogeneic Stem Cell Transplantation. Cureus. 2024 Jul 18;16(7):e64842. PMID: 39156368; PMCID: PMC11330277. https://doi.org/10.7759/cureus.64842
11. Kodali NK, Bhat LD, Phillip NE, Koya SF. Prevalence and associated factors of cardiovascular diseases among men and women aged 45 years and above: Analysis of the longitudinal ageing study in India, 2017-2019. Indian Heart J. 2023 Jan-Feb;75(1):31-35. https://doi.org/10.1016/j.ihj.2022.12.003 PMid:36549638 PMCid:PMC9986734
12. Conrad N, Molenberghs G, Verbeke G, Zaccardi F, Lawson C, Friday JM, Su H, Jhund PS, Sattar N, Rahimi K, Cleland JG, Khunti K, Budts W, McMurray JJV. Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study. BMJ. 2024 Jun 26;385:e078523. doi: 10.1136/bmj-2023-078523. Erratum in: BMJ. 2024 Oct 28;387:q2381. https://doi.org/10.1136/bmj.q2381 PMid:39467586 PMCid:PMC11514953
13. Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Vijayakumar K, Islam S, Iqbal R, Kazmi K, Rahman O, Yusuf R, Anjana RM, Mohan I, Rangarajan S, Gupta R, Yusuf S. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J. 2022 Aug 7;43(30):2831-2840. https://doi.org/10.1093/eurheartj/ehac249 PMid:35731159
14. Okobi OE, Nwogwugwu E, Ihezie CO, Olasupo OO, Emovon CI, Wambai-Sani H, Ezie OB, Afolabi AR, Erinne OC, O'dare RA. Cardiovascular Disease Patterns, Mortality, and Hospitalization Trends in Adults Over 18: Insights From the Behavioral Risk Factor Surveillance System Database. Cureus. 2024 Aug 10;16(8):e66604. https://doi.org/10.7759/cureus.66604
15. Sawarni S, Ranjan S, Kumar S. Nutraceuticals: A comprehensive review on its application in Neurological, Cardiovascular and Gastrointestinal disorder. Front Multidiscip Res Stud 2024; 1 (2): 109. https://doi.org/10.31531/fmrs.1000109
16. Fleenor BS, Berrones AJ. Arterial Stiffness: Implications and Interventions: Cham, Switzerland: Springer; 2015. https://doi.org/10.1007/978-3-319-24844-8
17. Fleenor BS, Carlini NA, Martens CR. Nutraceuticals in the prevention and therapeutic treatment of cardiovascular and cerebrovascular disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 2023 May 1;43(3):162-9. https://doi.org/10.1097/HCR.0000000000000773 PMid:36656154
18. Srijan G, Sagarika M, Piyasee P, Dipjyoti D, Sankalan D. Nutraceutical and Functional Foods in Disease Prevention; 2019. 403-431
19. Adetuyi BO, OdineGO,Olajide PA, Adetuyi OA, Atanda OO, Oloke JK. Nutraceuticals: role in metabolic disease, prevention and treatment. World News of Natural Sciences. 2022;42:1-2.
20. Maxwell J, Smith D, Brewster M, Eggleton S. Food as pharma as wellness products evolve, the distinction between food and medicine blurs. R&C Worlds Express. 2012.
21. Biotech for wellness: driving successful R&D and licensing in nutraceuticals through new business models and collaboration, research and markets. 2010.
22. Kumar P, Kumar N, Tushar O. Nutraceuticals- critical supplement for building a healthy India. World J Pharm Pharma Sci. 2016;5(3):579-594.
23. Olaiya CO, Soetan KO, Esan A. e role of nutraceuticals, functional foods and value added food products in the prevention and treatment of chronic diseases. African J Food Sci. 2016;10(10):185-193. https://doi.org/10.5897/AJFS2015.1402
24. Sosnowska B, Penson P, Banach M. e role of nutraceuticals in the prevention of cardiovascular disease. CardiovascDiagner. 2017;7(1):S21-S31. https://doi.org/10.21037/cdt.2017.03.20 PMid:28529919 PMCid:PMC5418215
25. Macfarlane S, Macfarlane G, Cummings H. Review article: prebiotics in the gastrointestinal tract. Alimentary Pharmacology and Therapeutics 2006, 24: 701-714 https://doi.org/10.1111/j.1365-2036.2006.03042.x PMid:16918875
26. Ahirwar NK, Singh R. An overview of nutraceuticals and their role in health applications. J Nutraceuticals Heal. 2023;1(1). https://doi.org/10.61577/jnh.2023.100003
27. Escott-Stump E, Mahan L. Krause's food, nutrition and diet therapy. 10. Philadelphia: WB Saunders Company; 2000, 553-565.
28. Cummings J. The effect of dietary fiber on fecal weight and composition. In: Spiller G, editor. Dietary fiber in human nutrition 2001, 183-252. https://doi.org/10.1201/9781420038514.ch4.4
29. Food and Agricultural Org World Health Org. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria; 2001.
30. Hord G. Eukaryotic macrobiotic crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annual Review Nutrition 2008, 28: 215-231. https://doi.org/10.1146/annurev.nutr.28.061807.155402 PMid:18489258
31. Devi M, Verma KK, Kumar I. Roles of Herbals in Paracetamol Induced Hepatotoxicty. Journal of Drug Delivery & Therapeutics. 2023 Sep 1;13(9):160-9. https://doi.org/10.22270/jddt.v13i9.5961
32. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Keivan K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Intl. (2014) 2014:186864. https://doi.org/10.1155/2014/186864 PMid:24877064 PMCid:PMC4022204
33. Zhong Y, Ma C, Shahidi F. Antioxidant and antiviral activities of lipophilic epigallocatechingallate (EGCG) derivatives. J Funct Foods. (2011) 4:87- 93. https://doi.org/10.1016/j.jff.2011.08.003 PMid:32288792 PMCid:PMC7105014
34. Abba Y, Hassim H, Hamzah H, Noordin MM. Antiviral activity of resveratrol against human and animal viruses. AdvVirol. (2015) 184241:1- 7. https://doi.org/10.1155/2015/184241 PMid:26693226 PMCid:PMC4676993
35. Singh S, Kola P, Kaur D, Singla G, Mishra V, Panesar PS, Mallikarjunan K, Krishania M. Therapeutic potential of nutraceuticals and dietary supplements in the prevention of viral diseases: A review. Frontiers in Nutrition. 2021 Sep 17;8:679312. https://doi.org/10.3389/fnut.2021.679312 PMid:34604272 PMCid:PMC8484310
36. Shirodkar S, Khanchey F, Babre N. Role of functional foods and nutraceuticals in nutrition and health. Academia Nutrition and Dietetics 2025;2. https://doi.org/10.20935/AcadNutr7676
37. Aziz T, Hussain N, Hameed Z, Lin L. Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Gut Microbes. 2024;16(1):2297864. https://doi.org/10.1080/19490976.2023.2297864 PMid:38174551 PMCid:PMC10773664
38. Adetuyi BO, OdineGO,Olajide PA, Adetuyi OA, Atanda OO, Oloke JK. Nutraceuticals: role in metabolic disease, prevention and treatment. World News of Natural Sciences. 2022;42:1-2.
39. Nwosu O, Ubaoji I. Nutraceutical: history, classification and market demand. In: Egbuna C, DableTupas G, eds. Functional Foods and Nutraceuticals. Springer International Publishing 2020, 13-22. https://doi.org/10.1007/978-3-030-42319-3_2
40. Adetuyi BO, OdineGO,Olajide PA, Adetuyi OA, Atanda OO, Oloke JK. Nutraceuticals: role in metabolic disease, prevention and treatment. World News of Natural Sciences. 2022;42:1-27.
41. Kapoor VK, Dureja J, Chadha R. Herbals in the control of ageing. Drug Discov Today. 2009;14(19-20):992-998 https://doi.org/10.1016/j.drudis.2009.06.014 PMid:19596462
42. Roy A, Jauhari N, Bharadvaja N. Medicinal plants as a potential source of chemopreventive agents. anticancer plants: natural products and biotechnological implements; Springer, 2018;2:109-139. https://doi.org/10.1007/978-981-10-8064-7_6
43. Debnath B, Singh WS, Das M, Goswami S, Singh MK, Maiti D, et al. Role of plant alkaloids on human health: a review of biological activities. Mater Today Chem. 2018;9:56-72. https://doi.org/10.1016/j.mtchem.2018.05.001
44. Sottor¬ I, Künzel S, Wiese J, Lipfert M, Preuke N, Sonnichsen FD, et al. Antitumor anthraquinones from an easter island sea anemone: animal or bacterial origin. Mar Drugs. 2019;17(3):154 https://doi.org/10.3390/md17030154 PMid:30841562 PMCid:PMC6471592
45. Prasad R, Prasad SB. A review on the chemistry and biological properties of rutin, a promising nutraceutical agent. Asian J Pharm Sci. 2019;5(S1):1-20 https://doi.org/10.31024/ajpp.2019.5.s1.1
46. Panche AN, Diwan AD, Chandra SR. Flavonoids: An overview. J Nutr Sci. 2016;5:e47. https://doi.org/10.1017/jns.2016.41 PMid:28620474 PMCid:PMC5465813
47. Ying W, Sevigny MB, Chen Y, Swanson RA. Poly (ADP ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. ProcNatlAcadSci USA. 2001;98(21):12227-12232. https://doi.org/10.1073/pnas.211202598 PMid:11593040 PMCid:PMC59796
48. Bors W, Michel C. Chemistry of the antioxidant e¬ect of polyphenols. Ann N Y Acad Sci. 2002;957(1):57-69. https://doi.org/10.1111/j.1749-6632.2002.tb02905.x PMid:12074961
49. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, Goh YJ, et al. Prebiotics: Why definitions matter. CurrOpinBiotechnol. 2016;37:1-7. https://doi.org/10.1016/j.copbio.2015.09.001 PMid:26431716 PMCid:PMC4744122
50. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev GastroenterolHepatol. 2017;14(8):491- 502. https://doi.org/10.1038/nrgastro.2017.75 PMid:28611480
51. Liu C, Ma N, Feng Y, Zhou M, Li H, Zhang X, et al. From probiotics to postbiotics Concepts and applications. In: Animal Research and One Health. Hoboken (NJ): John Wiley & Sons Inc; 2023. Volume 1, p. 92-114. https://doi.org/10.1002/aro2.7
52. Siram K, HabiburRahman SM, Balakumar K, Duganath N, Chandrasekar R, Hariprasad R. Pharmaceutical nanotechnology: A brief perspective on lipid drug delivery and its current scenario. In: Biomedical Applications of Nanoparticles. Amsterdam: Elsevier; 2019. p. 91-115. https://doi.org/10.1016/B978-0-12-816506-5.00005-X
53. Djuricic I, Calder PC. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients. 2021;13(7):2421. https://doi.org/10.3390/nu13072421 PMid:34371930 PMCid:PMC8308533
54. NurZulaikhaAzwaZuraini, MahendranSekar, Yuan Seng Wu, SiewHuaGan, Srinivasa Reddy Bonam, NurNajihahIzzati Mat Rani, M Yasmin Begum, Pei TengLum, VetriselvanSubramaniyan, Neeraj Kumar Fuloria&ShivkanyaFuloria (2021) Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action, Vascular Health and Risk Management, , 739-769, https://doi.org/10.2147/VHRM.S328096 PMid:34858028 PMCid:PMC8631183
55. Sharifi-Rad J, Rodrigues CF, Sharopov F, et al. Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds. Int J Environ Res Public Health. 2020;17(7):2326. https://doi.org/10.3390/ijerph17072326 PMid:32235611 PMCid:PMC7177934
56. Sawarni S, Ranjan S, Kumar S. Nutraceuticals: A comprehensive review on its application in Neurological, Cardiovascular and Gastrointestinal disorder. Front Multidiscip Res Stud 2024; 1 (2): 109. https://doi.org/10.31531/fmrs.1000109
57. Mohammadabadi T, Jain R. Cinnamon: a nutraceutical supplement for the cardiovascular system. Archives of Medical sciences. Atherosclerotic Diseases. 2024 Mar 30;9:e72. https://doi.org/10.5114/amsad/184245 PMid:38846056 PMCid:PMC11155465
Published
Abstract Display: 147 
PDF Downloads: 122 PDF Downloads: 28 How to Cite
Issue
Section
Copyright (c) 2025 Sharuti Koundal , Monika Devi , Kapil Kumar Verma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.